AORT

Artivion

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Medical Devices

Exchange

NYSE

County of HQ

United States

Next Earnings Date

05/04/26

Business Summary

Astera Labs operates in the semiconductor space, designing and enabling connectivity and infrastructure components that support high-performance computing systems. The business model monetizes rising data throughput demands by supplying critical silicon that sits inside servers, accelerators, and networking hardware. Cash generation is driven by converting design wins into scalable production revenue, supported by a 16.10% Operating Margin and strong capital efficiency metrics like 15.80% ROIC. Its moat is rooted in technical integration within complex hardware ecosystems, where switching costs, validation cycles, and performance reliability create durable customer relationships.

VALUATION

P/E

178.6

Market Cap ($M USD)

$1,824

Forward P/E

32.6

PEG

-

PRICE TO SALES

4

PRICE TO BOOK

4.1

EV / EBITDA

31.6

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$0.22

Next Year EPS Growth Estimate

$1.16

Next Year Revenue Growth Estimate

11.10%

Return on Equity (ROE)

2.20%

Operating Margin

6.10%

Debt-to-Equity

0.6

Piotroski F-Score

7

Altman Z-Score

3.4

Return on Invested Capital (ROIC)

4.00%%

Current Ratio

3.5

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 122x earnings and 31.4x sales, ALAB is priced like a hypergrowth franchise, yet the Forward P/E of 41.7 suggests the market expects a dramatic earnings ramp. The Altman Z-Score of 92.4 signals essentially zero near-term financial distress, reinforcing balance sheet strength and operational safety. With Return on Equity at 38.70% and ROIC at 15.80%, this is not a speculative science project—it is a profitable operator trading at a premium multiple. The market is not mispricing risk; it is aggressively pricing growth, and the question is whether earnings expansion justifies compressing from 122x to 41.7x forward. Financial health is strong, but valuation leaves no margin for operational disappointment.

AI Exposure / Tech Reliance

As a Semiconductor company in the Technology sector, ALAB sits directly in the capital-intensive backbone of AI infrastructure. Semiconductor demand is structurally tied to AI compute, data center expansion, and high-performance connectivity, positioning the company to benefit from secular AI spending cycles. Its 16.10% Operating Margin suggests it already converts industry tailwinds into real operating profit rather than just revenue growth.

The Bull Case

A GARP investor could justify ownership based on quality metrics that are objectively strong: 38.70% Return on Equity and 15.80% ROIC indicate efficient capital allocation and profitable reinvestment. The Piotroski F-Score of 6 signals fundamentally stable operations without major accounting deterioration, while a 16.10% Operating Margin in semiconductors shows competitive positioning. Debt / Equity at 20.30% combined with a 10.2 Current Ratio reflects a company that is not financially stretched and has liquidity flexibility. The dramatic compression from a 122 P/E to a 41.7 Forward P/E implies substantial earnings growth ahead, and if EPS Next Year (Est.) of $1.32 materializes, multiple contraction could occur alongside earnings expansion, cushioning downside.

The Bear Case

The valuation is the glaring risk: a 122 P/E and 31.4 Price / Sales ratio demand flawless execution. The PEG Forward is listed as -, removing a key valuation-growth anchor and increasing uncertainty around whether growth justifies the premium. Sales Growth Next Year is shown as $3.58, which lacks percentage context and makes it difficult to reconcile against such elevated multiples. Institutional Ownership % is listed as $202.65 and Short % of Float is -, creating opacity around positioning and sentiment; when transparency is weak and valuation is stretched, volatility risk rises sharply if growth underdelivers.

Market Sentiment & Smart Money

Short Interest %

4.30%

Analyst Consensus

1.63

Average Analyst Price Target

$51.43

Institutional Ownership %

91.10%

1-Year Beta

0.57

Insider Buying % (6 Mo)

4.50%%

Distance to 52-Week High

78.00%%

Distance to 52-Week Low

169.40%%